WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 7301 Infant (under 12 months) mortality rate: 342
GDP / capita (US$): 2'3751 Child (under 5 years) mortality rate: 422

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 28'121  27'797  27'474  27'156  26'846  23'184  18'111  14'385 
Births 577  584  593  606  621  760  688  590 
Surviving infants 558  564  572  583  597  713  624  511 
Pop. less than 5 years 2'852  2'911  2'984  3'072  3'178  3'469  2'949  2'328 
Pop. less than 15 years 9'508  9'633  9'751  9'860  9'962  9'366  7'646  5'960 
Female 15-49 years 7'741  7'550  7'358  7'168  6'982  5'651  4'191  3'309 

Number of reported case

(Click for retrospective incidence data for Nepal)
Diphtheria 1'079  103  138  94  146  268  82 
Japanese encephalitis 1'304  118  75  126  183 
Measles 1'279  1'861  3'362  2'359  190  9'397  182  561 
Mumps 34'034  29'134  35'874  39'023  29'022 
Pertussis 6'096  3'431  1'595  1'733  2'293  6'021  18  1'055 
Polio* 29  52 
Rubella 704  755  801  1'175  510 
Rubella (CRS) 16 
Tetanus (neonatal) 57  87  32  95  13  134 
Tetanus (total)** 883  377  359  193  547  305  35  116 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Nepal)
Vaccine year result method % card seen                                                
BCG 2010  97  DHS   34  99  97  96  97  94  97  98  22 
DTP1 2010  96  DHS   34  94  94  90  96  85  91 
DTP3 2010  92  DHS   34  92  92  90  92  82  80  80 
DTP4         
IPV1         
HepB_BD         
HepB3 2005  69  DHS   32  92  92  90  92  82 
Hib3          92  92  90  92 
JapEnc          78  72  62  54  47 
MCV1          88  88  86  88  86  77  68 
MCV2         
PCV1         
PCV3         
Pol3 2010  93  DHS   34  92  92  90  92  83  80  79 
Rota1         
Rota_last         
Rubella1          88 
TT2plus 2000  45  DHS   16  75  78  74  78  78  60  23 
PAB         
VAD1          99*  98  99*  99*  97 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Nepal)
BCG 99  97  96  97  94  84  74  22 
DTP1 94  94  90  96  85  84  68  28 
DTP3 92  92  90  92  82  74  43 
HepB3 92  92  90  92  82 
HepB_BD
Hib3 92  92  90  92 
MCV1 88  88  86  88  86  71  57 
MCV2
PAB 82  82  82  82  81  67  35 
PCV3
Pol3 92  92  90  92  83  74  42 
Rota_last

Number of districts in the country 75  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 57
From 80 to 89% 29
From 50 to 79% 13
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes From September 2014
Influenza Children; elderly; risk groups Yes
JE_LiveAtd 12-23 months No
MR 9 months; Yes
OPV 6, 10, 14 weeks; Yes
Pneumo_conj Yes From January 2015
TT Yes Pregnant women
Td Yes pregnant women
VitaminA 6, 12 months; Yes 6-59 months

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2016  2011-2016  2011-2016  2011-2016  2007-2011  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 75  75  56  26  10 

System performance

Total Nº districts in country number 75  75  75  75  75  75  75 
Nº districts with DTP3 coverage >=80% number 65  68  48  57  33  35  33 
% of districts with DTP3 coverage >=80% From 0 to 100% 87  91  64  76  44  47  44 
Nº districts with measles (MCV1) coverage >=95% number 22  25  22  25  17 
% of districts with MCV1 coverage >=95% From 0 to 100% 29  33  29  33  23 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 22  46  84  22  15  30 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.